Definitive Contract 75N91018C00009
Award Date 9/17/18
Potential Completion Date 3/16/19
Potential Value $225K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78756, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This definitive contract was awarded by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to Intelligent Automation, LLC. The $399,980 firm fixed price contract is for Phase I of the SBIR program's TOPIC 412, which seeks the development of a wearables-agnostic platform for continuous health monitoring and predictions to support cancer patients. The one-year period of performance will take place in Derwood,...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $225,000.00 firm-fixed-price contract to Klesis, LLC, a small business, to conduct research and development on "Enabling Clinical Decision Support for Guideline Based Cancer Symptom Management" under its Small Business Innovation Research (SBIR) program. This contract supports the overall goals of the SBIR program to stimulate innovation, strengthen the role of small businesses...
- This definitive contract from the Department of Health and Human Services' National Institutes of Health National Cancer Institute (HHS-NIH) is valued at $377,061 to Broad Axe Care Coordination LLC Locus Healtlh Division, doing business as Locus Health. It concerns SBIR Phase I Topic 406 to develop a cancer navigation platform, as requested in the National Institutes of Health and Centers for Disease Control and Prevention's solicitation for Small Business Innovation Research proposals. The...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $455,000.00 Firm Fixed Price Definitive Contract to Omicscraft LLC, a minority-owned, small disadvantaged business, for a cloud-based liquid-biopsy platform to support the Cancer Research Data Commons. This contract falls under the ISYSMET program, which focuses on the development of cloud-based pipelines for integrative analysis of multi-omics and imaging data. The...
- <p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>
- This is a $399,992 firm fixed price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Xanthoshealth, Inc., a small business concern, to develop "Software to Address Social Determinants of Health in Oncology Practices" under the NCI's SBIR program. The original solicitation sought proposals for innovative research across various biomedical and public health topics, including digital health tools, to contribute towards the NCI and Centers for Disease Control and...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a Small Business Innovation Research (SBIR) contract to Mimetas US, Inc., a small disadvantaged business, in the amount of $297,962.00. The contract is for the development of a 3D perfusable platform for high-throughput screening (HTS) across diverse racial/ethnic cancer specimens to generate racially diverse patient-derived xenograft (PDX)-derived prostate cancer cultures in...
- This definitive contract from the Department of Health and Human Services' National Institutes of Health National Cancer Institute (HHS-NIH) is valued at $392,519 to Vivosense Inc. for SBIR Topic 412: Vivosense Cancer Health Informatics Platform, Phase I. The contract is a firm fixed price award set aside for total small business under the SBIR solicitation seeking proposals for Phase I and Phase II contracts to conduct research and development supporting NIH and CDC agency missions. This...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The $225,000 Firm Fixed Price contract was awarded to Dimagi Inc., a self-certified small disadvantaged business, to develop a digital health solution to support long-term cancer survivorship using patient navigation. The contract is part of the NCI Cancer Moonshot program. Dimagi...